nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—ACHE—Alzheimer's disease	0.263	0.63	CbGaD
Pralidoxime—ACHE—Rivastigmine—Alzheimer's disease	0.161	0.31	CbGbCtD
Pralidoxime—BCHE—Alzheimer's disease	0.155	0.37	CbGaD
Pralidoxime—ACHE—Donepezil—Alzheimer's disease	0.129	0.248	CbGbCtD
Pralidoxime—BCHE—Rivastigmine—Alzheimer's disease	0.0969	0.187	CbGbCtD
Pralidoxime—ACHE—Galantamine—Alzheimer's disease	0.0828	0.16	CbGbCtD
Pralidoxime—BCHE—Galantamine—Alzheimer's disease	0.0499	0.0961	CbGbCtD
Pralidoxime—Hyperventilation—Donepezil—Alzheimer's disease	0.00185	0.0676	CcSEcCtD
Pralidoxime—Hyperventilation—Rivastigmine—Alzheimer's disease	0.00165	0.0601	CcSEcCtD
Pralidoxime—Inflammation—Rivastigmine—Alzheimer's disease	0.00117	0.0426	CcSEcCtD
Pralidoxime—Muscular weakness—Galantamine—Alzheimer's disease	0.00105	0.0385	CcSEcCtD
Pralidoxime—Diplopia—Memantine—Alzheimer's disease	0.000841	0.0307	CcSEcCtD
Pralidoxime—Haemoglobin—Galantamine—Alzheimer's disease	0.000831	0.0303	CcSEcCtD
Pralidoxime—Haemorrhage—Galantamine—Alzheimer's disease	0.000827	0.0302	CcSEcCtD
Pralidoxime—Diplopia—Rivastigmine—Alzheimer's disease	0.000823	0.03	CcSEcCtD
Pralidoxime—Muscular weakness—Donepezil—Alzheimer's disease	0.000817	0.0298	CcSEcCtD
Pralidoxime—Muscular weakness—Memantine—Alzheimer's disease	0.000742	0.0271	CcSEcCtD
Pralidoxime—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000726	0.0265	CcSEcCtD
Pralidoxime—Vision blurred—Galantamine—Alzheimer's disease	0.000679	0.0247	CcSEcCtD
Pralidoxime—Agitation—Galantamine—Alzheimer's disease	0.000662	0.0241	CcSEcCtD
Pralidoxime—Haemoglobin—Donepezil—Alzheimer's disease	0.000644	0.0235	CcSEcCtD
Pralidoxime—Haemorrhage—Donepezil—Alzheimer's disease	0.000641	0.0234	CcSEcCtD
Pralidoxime—Drowsiness—Rivastigmine—Alzheimer's disease	0.000634	0.0231	CcSEcCtD
Pralidoxime—Haemoglobin—Memantine—Alzheimer's disease	0.000585	0.0213	CcSEcCtD
Pralidoxime—Haemorrhage—Memantine—Alzheimer's disease	0.000582	0.0212	CcSEcCtD
Pralidoxime—Tachycardia—Galantamine—Alzheimer's disease	0.000573	0.0209	CcSEcCtD
Pralidoxime—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000572	0.0209	CcSEcCtD
Pralidoxime—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000569	0.0208	CcSEcCtD
Pralidoxime—Vision blurred—Donepezil—Alzheimer's disease	0.000526	0.0192	CcSEcCtD
Pralidoxime—Somnolence—Galantamine—Alzheimer's disease	0.000522	0.0191	CcSEcCtD
Pralidoxime—Agitation—Donepezil—Alzheimer's disease	0.000513	0.0187	CcSEcCtD
Pralidoxime—Vision blurred—Memantine—Alzheimer's disease	0.000477	0.0174	CcSEcCtD
Pralidoxime—Vision blurred—Rivastigmine—Alzheimer's disease	0.000467	0.017	CcSEcCtD
Pralidoxime—Agitation—Memantine—Alzheimer's disease	0.000466	0.017	CcSEcCtD
Pralidoxime—Agitation—Rivastigmine—Alzheimer's disease	0.000455	0.0166	CcSEcCtD
Pralidoxime—Somnolence—Donepezil—Alzheimer's disease	0.000405	0.0148	CcSEcCtD
Pralidoxime—Tachycardia—Memantine—Alzheimer's disease	0.000404	0.0147	CcSEcCtD
Pralidoxime—Tachycardia—Rivastigmine—Alzheimer's disease	0.000395	0.0144	CcSEcCtD
Pralidoxime—Pain—Donepezil—Alzheimer's disease	0.000389	0.0142	CcSEcCtD
Pralidoxime—Dizziness—Galantamine—Alzheimer's disease	0.000389	0.0142	CcSEcCtD
Pralidoxime—Headache—Galantamine—Alzheimer's disease	0.000368	0.0134	CcSEcCtD
Pralidoxime—Somnolence—Memantine—Alzheimer's disease	0.000368	0.0134	CcSEcCtD
Pralidoxime—Somnolence—Rivastigmine—Alzheimer's disease	0.00036	0.0131	CcSEcCtD
Pralidoxime—Pain—Memantine—Alzheimer's disease	0.000354	0.0129	CcSEcCtD
Pralidoxime—Nausea—Galantamine—Alzheimer's disease	0.000349	0.0127	CcSEcCtD
Pralidoxime—Pain—Rivastigmine—Alzheimer's disease	0.000346	0.0126	CcSEcCtD
Pralidoxime—Dizziness—Donepezil—Alzheimer's disease	0.000301	0.011	CcSEcCtD
Pralidoxime—Headache—Donepezil—Alzheimer's disease	0.000285	0.0104	CcSEcCtD
Pralidoxime—ACHE—Peptide hormone metabolism—MME—Alzheimer's disease	0.000281	0.00803	CbGpPWpGaD
Pralidoxime—Dizziness—Memantine—Alzheimer's disease	0.000273	0.00997	CcSEcCtD
Pralidoxime—ACHE—Glycerophospholipid biosynthesis—CHAT—Alzheimer's disease	0.000271	0.00772	CbGpPWpGaD
Pralidoxime—Nausea—Donepezil—Alzheimer's disease	0.00027	0.00986	CcSEcCtD
Pralidoxime—ACHE—Melatonin metabolism and effects—CALM1—Alzheimer's disease	0.000268	0.00765	CbGpPWpGaD
Pralidoxime—Dizziness—Rivastigmine—Alzheimer's disease	0.000267	0.00975	CcSEcCtD
Pralidoxime—ACHE—Melatonin metabolism and effects—APOE—Alzheimer's disease	0.000267	0.00762	CbGpPWpGaD
Pralidoxime—Headache—Memantine—Alzheimer's disease	0.000259	0.00945	CcSEcCtD
Pralidoxime—Headache—Rivastigmine—Alzheimer's disease	0.000253	0.00924	CcSEcCtD
Pralidoxime—BCHE—Peptide hormone metabolism—MME—Alzheimer's disease	0.000251	0.00716	CbGpPWpGaD
Pralidoxime—Nausea—Memantine—Alzheimer's disease	0.000246	0.00896	CcSEcCtD
Pralidoxime—BCHE—Glycerophospholipid biosynthesis—CHAT—Alzheimer's disease	0.000241	0.00689	CbGpPWpGaD
Pralidoxime—Nausea—Rivastigmine—Alzheimer's disease	0.00024	0.00876	CcSEcCtD
Pralidoxime—ACHE—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.000234	0.00668	CbGpPWpGaD
Pralidoxime—ACHE—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	0.000231	0.0066	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.000209	0.00596	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—CTSD—Alzheimer's disease	0.000204	0.00583	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—PPARGC1A—Alzheimer's disease	0.000198	0.00566	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—ACHE—Alzheimer's disease	0.000192	0.00549	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—CHAT—Alzheimer's disease	0.000189	0.00539	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—BCHE—Alzheimer's disease	0.000188	0.00536	CbGpPWpGaD
Pralidoxime—BCHE—Glycerophospholipid biosynthesis—ACHE—Alzheimer's disease	0.000187	0.00534	CbGpPWpGaD
Pralidoxime—ACHE—Glycerophospholipid biosynthesis—BCHE—Alzheimer's disease	0.000183	0.00521	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—CTSD—Alzheimer's disease	0.000182	0.0052	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—ACE—Alzheimer's disease	0.000182	0.00519	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—SLC18A3—Alzheimer's disease	0.000179	0.00512	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—CHAT—Alzheimer's disease	0.000168	0.00481	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.000165	0.00471	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.000165	0.00471	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—ACE—Alzheimer's disease	0.000162	0.00463	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—SLC18A3—Alzheimer's disease	0.00016	0.00457	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—IL1B—Alzheimer's disease	0.000157	0.00449	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—PLAU—Alzheimer's disease	0.000154	0.00438	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.000147	0.0042	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.000147	0.0042	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000146	0.00418	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—INPP5D—Alzheimer's disease	0.000145	0.00413	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—ESR1—Alzheimer's disease	0.000145	0.00412	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—NOS2—Alzheimer's disease	0.000141	0.00403	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.00014	0.004	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.00014	0.004	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000137	0.0039	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—ACHE—Alzheimer's disease	0.000131	0.00373	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000131	0.00373	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—CREB1—Alzheimer's disease	0.00013	0.00371	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—INS—Alzheimer's disease	0.000129	0.00369	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—INPP5D—Alzheimer's disease	0.000129	0.00368	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—BCHE—Alzheimer's disease	0.000128	0.00364	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000127	0.00361	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GRIK1—Alzheimer's disease	0.000126	0.00361	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—CHRNA7—Alzheimer's disease	0.000126	0.00361	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000125	0.00357	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000125	0.00357	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000125	0.00357	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000123	0.00351	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000118	0.00338	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000115	0.00328	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—TNF—Alzheimer's disease	0.000114	0.00326	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—LEP—Alzheimer's disease	0.000113	0.00323	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CHRNA7—Alzheimer's disease	0.000113	0.00322	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GRIK1—Alzheimer's disease	0.000113	0.00322	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000112	0.00318	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—BCL2—Alzheimer's disease	0.000109	0.00312	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—TOMM40—Alzheimer's disease	0.000108	0.00307	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000108	0.00307	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GRIK2—Alzheimer's disease	0.000108	0.00307	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—CHAT—Alzheimer's disease	0.000108	0.00307	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000106	0.00302	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000106	0.00301	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ADAMTS2—Alzheimer's disease	0.000101	0.00289	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—LEP—Alzheimer's disease	0.000101	0.00288	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.0001	0.00285	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	9.83e-05	0.00281	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	9.77e-05	0.00279	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	9.71e-05	0.00277	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—INS—Alzheimer's disease	9.66e-05	0.00276	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—TOMM40—Alzheimer's disease	9.6e-05	0.00274	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	9.59e-05	0.00274	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CHAT—Alzheimer's disease	9.59e-05	0.00274	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GRIK2—Alzheimer's disease	9.59e-05	0.00274	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ATP5A1—Alzheimer's disease	9.59e-05	0.00274	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GRIA1—Alzheimer's disease	9.58e-05	0.00273	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	9.48e-05	0.0027	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	9.44e-05	0.00269	CbGpPWpGaD
Pralidoxime—ACHE—Peptide hormone metabolism—IGF1—Alzheimer's disease	9.34e-05	0.00267	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	9.25e-05	0.00264	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—CHRNB2—Alzheimer's disease	9.08e-05	0.00259	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	9.04e-05	0.00258	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ADAMTS2—Alzheimer's disease	9.02e-05	0.00257	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	8.94e-05	0.00255	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—MAPK8—Alzheimer's disease	8.85e-05	0.00253	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—SLC30A6—Alzheimer's disease	8.77e-05	0.0025	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	8.71e-05	0.00249	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—INS—Alzheimer's disease	8.62e-05	0.00246	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ATP5A1—Alzheimer's disease	8.55e-05	0.00244	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GRIA1—Alzheimer's disease	8.55e-05	0.00244	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—IGF1—Alzheimer's disease	8.34e-05	0.00238	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	8.25e-05	0.00235	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—CHRNA4—Alzheimer's disease	8.24e-05	0.00235	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—TPP1—Alzheimer's disease	8.15e-05	0.00233	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CHRNB2—Alzheimer's disease	8.1e-05	0.00231	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	8.07e-05	0.0023	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	7.98e-05	0.00228	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—SLC30A6—Alzheimer's disease	7.82e-05	0.00223	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	7.53e-05	0.00215	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—ACHE—Alzheimer's disease	7.44e-05	0.00212	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CHRNA4—Alzheimer's disease	7.35e-05	0.0021	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—TPP1—Alzheimer's disease	7.27e-05	0.00207	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—BCHE—Alzheimer's disease	7.26e-05	0.00207	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—DLG4—Alzheimer's disease	7.09e-05	0.00202	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	7.01e-05	0.002	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GRIN2B—Alzheimer's disease	6.93e-05	0.00198	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—PLCB1—Alzheimer's disease	6.85e-05	0.00195	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	6.61e-05	0.00189	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—DHCR24—Alzheimer's disease	6.52e-05	0.00186	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ADAMTS4—Alzheimer's disease	6.52e-05	0.00186	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—DLG4—Alzheimer's disease	6.32e-05	0.0018	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GRIN2B—Alzheimer's disease	6.18e-05	0.00176	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—PLCB1—Alzheimer's disease	6.11e-05	0.00174	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	6.08e-05	0.00173	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	5.9e-05	0.00168	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—DHCR24—Alzheimer's disease	5.82e-05	0.00166	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ADAMTS4—Alzheimer's disease	5.81e-05	0.00166	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	5.72e-05	0.00163	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—IL6—Alzheimer's disease	5.65e-05	0.00161	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	5.65e-05	0.00161	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CA4—Alzheimer's disease	5.54e-05	0.00158	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	5.42e-05	0.00155	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	5.42e-05	0.00155	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MME—Alzheimer's disease	5.31e-05	0.00152	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GAPDHS—Alzheimer's disease	5.21e-05	0.00149	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	5.11e-05	0.00146	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	5.08e-05	0.00145	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—PRKCG—Alzheimer's disease	5.07e-05	0.00145	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CA4—Alzheimer's disease	4.95e-05	0.00141	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ATP5A1—Alzheimer's disease	4.94e-05	0.00141	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—HSPD1—Alzheimer's disease	4.94e-05	0.00141	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	4.9e-05	0.0014	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	4.89e-05	0.00139	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.83e-05	0.00138	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MME—Alzheimer's disease	4.74e-05	0.00135	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLD3—Alzheimer's disease	4.71e-05	0.00134	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.66e-05	0.00133	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GAPDHS—Alzheimer's disease	4.65e-05	0.00133	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—PRKCG—Alzheimer's disease	4.52e-05	0.00129	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HSD17B10—Alzheimer's disease	4.52e-05	0.00129	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	4.42e-05	0.00126	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ATP5A1—Alzheimer's disease	4.41e-05	0.00126	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—HSPD1—Alzheimer's disease	4.41e-05	0.00126	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—CALM1—Alzheimer's disease	4.38e-05	0.00125	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	4.37e-05	0.00125	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP46A1—Alzheimer's disease	4.35e-05	0.00124	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	4.27e-05	0.00122	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLD3—Alzheimer's disease	4.21e-05	0.0012	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	4.21e-05	0.0012	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ND1—Alzheimer's disease	4.2e-05	0.0012	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—EIF2S1—Alzheimer's disease	4.17e-05	0.00119	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	4.16e-05	0.00119	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	4.11e-05	0.00117	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	4.05e-05	0.00116	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HSD17B10—Alzheimer's disease	4.03e-05	0.00115	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.94e-05	0.00112	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CALM1—Alzheimer's disease	3.91e-05	0.00112	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP46A1—Alzheimer's disease	3.88e-05	0.00111	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CTSD—Alzheimer's disease	3.86e-05	0.0011	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	3.76e-05	0.00107	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.76e-05	0.00107	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—CREB1—Alzheimer's disease	3.75e-05	0.00107	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ND1—Alzheimer's disease	3.75e-05	0.00107	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—EIF2S1—Alzheimer's disease	3.72e-05	0.00106	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ACHE—Alzheimer's disease	3.63e-05	0.00104	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—GSK3A—Alzheimer's disease	3.61e-05	0.00103	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—BCHE—Alzheimer's disease	3.55e-05	0.00101	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	3.46e-05	0.000987	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CTSD—Alzheimer's disease	3.44e-05	0.000981	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ACE—Alzheimer's disease	3.44e-05	0.00098	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.35e-05	0.000956	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CREB1—Alzheimer's disease	3.35e-05	0.000955	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	3.24e-05	0.000923	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—GSK3A—Alzheimer's disease	3.22e-05	0.000919	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	3.19e-05	0.000911	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ACE—Alzheimer's disease	3.07e-05	0.000875	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.95e-05	0.000841	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.93e-05	0.000836	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.89e-05	0.000824	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—IGF2—Alzheimer's disease	2.75e-05	0.000784	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.74e-05	0.000781	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CHAT—Alzheimer's disease	2.71e-05	0.000772	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TPI1—Alzheimer's disease	2.71e-05	0.000772	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.63e-05	0.00075	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MAOB—Alzheimer's disease	2.6e-05	0.00074	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GAPDH—Alzheimer's disease	2.5e-05	0.000713	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.47e-05	0.000705	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGF2—Alzheimer's disease	2.45e-05	0.000699	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.45e-05	0.000698	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CHAT—Alzheimer's disease	2.42e-05	0.000689	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TPI1—Alzheimer's disease	2.42e-05	0.000689	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—A2M—Alzheimer's disease	2.41e-05	0.000688	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.41e-05	0.000688	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MAOB—Alzheimer's disease	2.32e-05	0.000661	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GAPDH—Alzheimer's disease	2.23e-05	0.000636	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	2.2e-05	0.000629	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	2.18e-05	0.000623	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—A2M—Alzheimer's disease	2.15e-05	0.000614	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.15e-05	0.000614	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—LEP—Alzheimer's disease	2.13e-05	0.000609	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—INPP5D—Alzheimer's disease	2.08e-05	0.000592	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.04e-05	0.000581	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—F2—Alzheimer's disease	2.01e-05	0.000574	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ENO1—Alzheimer's disease	1.97e-05	0.000561	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTGS1—Alzheimer's disease	1.97e-05	0.000561	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2D6—Alzheimer's disease	1.93e-05	0.00055	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.92e-05	0.000548	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—LEP—Alzheimer's disease	1.9e-05	0.000543	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ACHE—Alzheimer's disease	1.87e-05	0.000534	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—INPP5D—Alzheimer's disease	1.85e-05	0.000528	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—BCHE—Alzheimer's disease	1.83e-05	0.000522	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—INS—Alzheimer's disease	1.82e-05	0.00052	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—F2—Alzheimer's disease	1.8e-05	0.000512	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CCL2—Alzheimer's disease	1.79e-05	0.000512	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—IGF1—Alzheimer's disease	1.76e-05	0.000503	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTGS1—Alzheimer's disease	1.76e-05	0.000501	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ENO1—Alzheimer's disease	1.76e-05	0.000501	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLCB1—Alzheimer's disease	1.73e-05	0.000492	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2D6—Alzheimer's disease	1.72e-05	0.000491	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.69e-05	0.000483	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCA1—Alzheimer's disease	1.67e-05	0.000477	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—INS—Alzheimer's disease	1.63e-05	0.000464	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CCL2—Alzheimer's disease	1.6e-05	0.000457	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGF1—Alzheimer's disease	1.57e-05	0.000449	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLCB1—Alzheimer's disease	1.54e-05	0.000439	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.51e-05	0.000431	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCA1—Alzheimer's disease	1.49e-05	0.000426	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPARGC1A—Alzheimer's disease	1.44e-05	0.000411	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HMOX1—Alzheimer's disease	1.44e-05	0.000409	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—LPL—Alzheimer's disease	1.31e-05	0.000374	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPARGC1A—Alzheimer's disease	1.29e-05	0.000367	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HMOX1—Alzheimer's disease	1.28e-05	0.000365	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTHFR—Alzheimer's disease	1.18e-05	0.000337	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—LPL—Alzheimer's disease	1.17e-05	0.000334	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CALM1—Alzheimer's disease	1.1e-05	0.000315	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOE—Alzheimer's disease	1.1e-05	0.000314	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CAV1—Alzheimer's disease	1.09e-05	0.000311	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTHFR—Alzheimer's disease	1.05e-05	0.000301	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CALM1—Alzheimer's disease	9.85e-06	0.000281	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOE—Alzheimer's disease	9.82e-06	0.00028	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CAV1—Alzheimer's disease	9.73e-06	0.000277	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPARG—Alzheimer's disease	9.58e-06	0.000273	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—INS—Alzheimer's disease	9.4e-06	0.000268	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPARG—Alzheimer's disease	8.55e-06	0.000244	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—INS—Alzheimer's disease	8.39e-06	0.000239	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NOS3—Alzheimer's disease	8.24e-06	0.000235	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTGS2—Alzheimer's disease	7.54e-06	0.000215	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NOS3—Alzheimer's disease	7.35e-06	0.00021	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTGS2—Alzheimer's disease	6.73e-06	0.000192	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AKT1—Alzheimer's disease	3.79e-06	0.000108	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AKT1—Alzheimer's disease	3.38e-06	9.64e-05	CbGpPWpGaD
